
Beam Therapeutics Inc.
BEAMNasdaqCIK 1745999HealthcareFiscal year ends Dec 31
Reports and events: 110 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-10-1908:50 ET | 8-K | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-258963 |
| 2023-08-0807:30 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-039364 |
| 2023-08-0807:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-039356 |
| 2023-06-0816:31 ET | 8-K | 5.07 Shareholder vote results | 0000950170-23-027026 |
| 2023-05-1016:56 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-23-140832 |
| 2023-05-1007:31 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-020090 |
| 2023-05-1007:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-020063 |
| 2023-04-2116:06 ET | DEF 14A | Proxy statement | 0000950170-23-013837 |
| 2023-02-2807:31 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-004866 |
| 2023-02-2807:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-004858 |
| 2023-01-0907:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-004131 |
| 2022-11-0707:31 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-022322 |
| 2022-11-0707:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-022313 |
| 2022-09-0706:47 ET | 8-K | 8.01 Other events | 0000950170-22-018147 |
| 2022-08-3007:08 ET | 8-K | 8.01 Other events | 0000950170-22-017868 |
| 2022-08-0907:31 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-015755 |
| 2022-08-0907:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-015736 |
| 2022-08-0106:50 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-22-013559 |
| 2022-06-1016:57 ET | 8-K | 5.07 Shareholder vote results | 0000950170-22-011501 |
| 2022-05-0907:33 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000950170-22-008238 |
| 2022-05-0907:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-008231 |
| 2022-04-2216:24 ET | DEF 14A | Proxy statementPeriod 2022-06-08 | 0000950170-22-006016 |
| 2022-02-2807:31 ET | 10-K | Annual reportPeriod 2021-12-31 | 0000950170-22-002166 |
| 2022-02-2807:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-002162 |
| 2022-01-1006:45 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-22-000163 |
| 2021-11-0808:31 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0000950170-21-003317 |
| 2021-11-0806:19 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-21-003291 |
| 2021-08-1007:46 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0000950170-21-001110 |
| 2021-08-1006:46 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-21-001108 |
| 2021-07-0716:01 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-209865 |
| 2021-06-1116:10 ET | 8-K | 5.07 Shareholder vote results | 0001564590-21-032654 |
| 2021-05-2416:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001564590-21-029509 |
| 2021-05-1116:16 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001564590-21-026555 |
| 2021-05-1107:48 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-21-026294 |
| 2021-04-2316:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001564590-21-020341 |
| 2021-04-2316:05 ET | DEF 14A | Proxy statementPeriod 2021-06-09 | 0001564590-21-020335 |
| 2021-04-0107:48 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-103255 |
| 2021-03-1517:01 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001564590-21-013190 |
| 2021-03-1506:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-21-012996 |
| 2021-02-2308:43 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-051599 |
| 2021-01-1906:46 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-010753 |
| 2021-01-1318:11 ET | 8-K | 7.01 Regulation FD disclosure | 0001564590-21-001028 |
| 2021-01-1207:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-000920 |
| 2021-01-1116:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001564590-21-000861 |
| 2020-11-1006:49 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001564590-20-052723 |
| 2020-11-1006:41 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-20-052718 |
| 2020-09-2816:02 ET | S-1 | Registration statement | 0001193125-20-256298 |
| 2020-08-1207:45 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001564590-20-039490 |
| 2020-08-1207:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-20-039482 |
| 2020-06-2909:28 ET | 8-K | 7.01 Regulation FD disclosure | 0000950123-20-006470 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 12:58 ET. Listed shows no prices and gives no investment advice.